E-ISSN 2367-699X | ISSN 2367-7414
 

Original Article 


TRENDS IN PRESCRIBING AND UTILIZATION OF ANTIDIABETIC DRUGS IN PRIMARY HEALTH CARE IN ALBANIA DURING 2004-2014

Laerta Kakariqi.

Abstract
Aim: To describe trends in out-of-hospital utilization and prescribing of antidiabetic drugs in Albania using the Anatomic Therapeutic Chemical Classification/ Defined Daily Dose -(ATC/DDD methodology).
Methods: The study was retrospective and we analyzed the prescription and consumption of these drugs classes in the primary health care in Albania during 2004-2014.
All data were collected from Health Insurance Institute (HII) and analysed reflecting the ambulatory and outpatient use for the period 2004-2014. The data about the consumption of drugs were expressed as a number of Defined Daily Dose (DDDs) /1000 inhabitants/day.
For all the period under study 2004-2014, there were collected and analysed the data of import and domestic production of drugs, which altogether represent the real consumption of drugs in the country. These data were subsequently included in a comparative analysis with the utilization data according to the HII.
Results: The consumption of all insulins were 1.80-5.64 DDD/1000 inhabitants/day (respectively 2004-2014). The consumption of insulin fast-acting were 0.47-2.59 DDD/1000 inhabitants/day (respectively 2004-2014).
The consumption of insulin intermediate-acting were 0.38-0.70 DDD/1000 inhabitants/day (respectively 2004-2014).
The consumption of insulin intermediate-acting combined with insulin fast-acting were 0.95-1.18 DDD/1000 inhabitants/day. The consumption of insulin long-acting were 0.00-1.41 DDD/1000 inhabitants/day.
The most prescribed oral antidiabetic agent was metformin 3.04-7.45 DDD/1000 inhabitants/day (respectively 2004-2014).
The consumption of glibenclamide was 3.55-5.76 DDD/1000 inhabitants/day (respectively 2004-2007).
Conclusions: There is an increase in Antidiabetic drugs use from HII covering, while there is a significant increase in their use from out-of-pocket expenditure during 2004-2014.
There can be noted a visible discrepancy between the consumption of antidiabetic drugs and the diabetes mellitus morbidity, which indicates that only a part of patients with diabetes mellitus do benefit from the reimbursement scheme.

Key words: Key words: Drug utilization, DDD, antidiabetics drugs


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Laerta Kakariqi
on Google
on Google Scholar


REFERENCES
1. Ogbera A, Fasanmade O, Ohwovoriole A. High costs, low awareness and a lack of care. The diabetic foot in Nigeria. Diabetes Voice, 51:30.32, 2006
2. National Diabetes Fact Sheet. American Diabetes Association Web site. Available at: http://www.diabetes.org/main/info/facts/factsnatl.jsp. 2002.
3.UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998 [DOI via Crossref]   
4.Okano GJ, Rascati KL, Wilson JP, Redmund DD, Grabenstein JD, Brixner DI: Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin- converting enzyme or calcium channel blocker. Clinical Therapeutics 19:1433-1435, 1997 [DOI via Crossref]   
5. Venturini F, Sung JCY, Nichol MB, Sellner JC: Utilization patterns of antidepressant medications in a patient population served by a primary care group. Journal of managed care pharmacy 5:243-249, 1999 [DOI via Crossref]   
6.Health Insurance Institute; Ministry of Health;
7. Institute of Statistics; INSTAT Albania
8. General Customs Directorate, Ministry of Finance, Albania
9. Boccuzzi Associates. Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. Population. Diabetes Care, Volume 24, Number 8, 2001.
10. Arteagoitia JM, Larranaga MI, Rodriguez JL, Fernandez I, Pinies JA. Incidence, prevalence and coronary heart disease risk level in known type 2 diabetes: a sentinel practice network study in the Basque county, Spain. Diabetologia, 46:899-909, 2003. [DOI via Crossref]    [Pubmed]   
11.Wild S, Roglic G, Green A, Sicree R, King H. The global prevalence of diabetes. Estimation for the year 2000 and projection for 2030. Diabetes Care, 27:1047-1053, 2004. [DOI via Crossref]    [Pubmed]   
12. No authors listed. Therapeutic Guidelines Ltd, 2008.
13. http://www.ema.europa.eu/humandocs/PDFs/EPAR/Lantus/40847409en.pdf, http://www.ema.europa.eu/humandocs/PDFs/EPAR/Lantus/47063209en.pdf, 2010
14. http://www.diabetologia-journal.org/cancer.html, 2010
15.Gruppo di lavoro OsMed. LÂ’uso dei farmaci in Italia. Rapporto nazionale anno 2009. Roma: Il Pensiero Scientifico Editore, 2010.
16. The American Association of Clinical Endocrinologists. Medical guidelines for the management of diabetes mellitus: the AACE systems of intensive diabetes self-management - 2002 update. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 8 (Suppl 1):41-65, 2002.
17. International Diabetes Federation. A desktop guide to type 2 diabetes. Diabetic Medicine; 16:716-30, 1999. [DOI via Crossref]    [Pubmed]   
18. Hungarian Diabetes Association. The classification, the treatment and the care of diabetes mellitus: national guideline. Diabetologia Hungarica; 7:44-57, 1999.
19. Hanko B, Tukarcs E, Kumli P, Vincze Z. Antidiabetic drug utilization in Hungary. Pharmacy World& Science; 27: 263-265; Springer 2005.

How to Cite this Article
Pubmed Style

Laerta Kakariqi. TRENDS IN PRESCRIBING AND UTILIZATION OF ANTIDIABETIC DRUGS IN PRIMARY HEALTH CARE IN ALBANIA DURING 2004-2014. Int J Surg Med. 2016; 2(2): 77-82. doi:10.5455/ijsm.antidiabeticdrugs


Web Style

Laerta Kakariqi. TRENDS IN PRESCRIBING AND UTILIZATION OF ANTIDIABETIC DRUGS IN PRIMARY HEALTH CARE IN ALBANIA DURING 2004-2014. http://www.ejos.org/?mno=218946 [Access: November 03, 2020]. doi:10.5455/ijsm.antidiabeticdrugs


AMA (American Medical Association) Style

Laerta Kakariqi. TRENDS IN PRESCRIBING AND UTILIZATION OF ANTIDIABETIC DRUGS IN PRIMARY HEALTH CARE IN ALBANIA DURING 2004-2014. Int J Surg Med. 2016; 2(2): 77-82. doi:10.5455/ijsm.antidiabeticdrugs



Vancouver/ICMJE Style

Laerta Kakariqi. TRENDS IN PRESCRIBING AND UTILIZATION OF ANTIDIABETIC DRUGS IN PRIMARY HEALTH CARE IN ALBANIA DURING 2004-2014. Int J Surg Med. (2016), [cited November 03, 2020]; 2(2): 77-82. doi:10.5455/ijsm.antidiabeticdrugs



Harvard Style

Laerta Kakariqi (2016) TRENDS IN PRESCRIBING AND UTILIZATION OF ANTIDIABETIC DRUGS IN PRIMARY HEALTH CARE IN ALBANIA DURING 2004-2014. Int J Surg Med, 2 (2), 77-82. doi:10.5455/ijsm.antidiabeticdrugs



Turabian Style

Laerta Kakariqi. 2016. TRENDS IN PRESCRIBING AND UTILIZATION OF ANTIDIABETIC DRUGS IN PRIMARY HEALTH CARE IN ALBANIA DURING 2004-2014. International Journal of Surgery and Medicine, 2 (2), 77-82. doi:10.5455/ijsm.antidiabeticdrugs



Chicago Style

Laerta Kakariqi. "TRENDS IN PRESCRIBING AND UTILIZATION OF ANTIDIABETIC DRUGS IN PRIMARY HEALTH CARE IN ALBANIA DURING 2004-2014." International Journal of Surgery and Medicine 2 (2016), 77-82. doi:10.5455/ijsm.antidiabeticdrugs



MLA (The Modern Language Association) Style

Laerta Kakariqi. "TRENDS IN PRESCRIBING AND UTILIZATION OF ANTIDIABETIC DRUGS IN PRIMARY HEALTH CARE IN ALBANIA DURING 2004-2014." International Journal of Surgery and Medicine 2.2 (2016), 77-82. Print. doi:10.5455/ijsm.antidiabeticdrugs



APA (American Psychological Association) Style

Laerta Kakariqi (2016) TRENDS IN PRESCRIBING AND UTILIZATION OF ANTIDIABETIC DRUGS IN PRIMARY HEALTH CARE IN ALBANIA DURING 2004-2014. International Journal of Surgery and Medicine, 2 (2), 77-82. doi:10.5455/ijsm.antidiabeticdrugs